|
Market Closed -
Nasdaq
21:00:00 23/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 34.75 USD | -1.33% |
|
+1.02% | +12.82% |
| 06:07am | Hansa Biopharma brings in two new board members | FW |
| 05:55am | Nordic stocks in North America, Astra Zeneca fell 1.2% | FW |
Chart calendar Genmab A/S
Upcoming events on Genmab A/S
| 07/10/2026 | Extraordinary General Meeting | 14:00 |
| 07/10/2026 | Présentation aux Actionnaires / Analystes | 14:00 |
| 05/11/2026 | Earnings release - Q3 2026 | 16:00 |
Past events on Genmab A/S
| 06/08/2026 | Earnings release - Q2 2026 | 16:00 |
| 06/08/2026 | Earnings presentation | 17:00 |
| 07/05/2026 | Earnings presentation | 17:00 |
| 07/05/2026 | Earnings release - Q1 2026 | 16:00 |
| 19/03/2026 | Présentation aux Actionnaires / Analystes | 13:00 |
| 19/03/2026 | Annual General Meeting | 13:00 |
| 17/02/2026 | Earnings release - Annual 2025 | 16:00 |
| 17/02/2026 | Earnings presentation | 17:00 |
| 11/12/2025 | Information meeting | 16:00 |
| 06/11/2025 | Earnings release - Q3 2025 | |
| 06/11/2025 | Earnings presentation | 17:00 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million DKK | Released Forecast Spread | 16 474 16 380 0.58% | 21 526 21 291 1.1% | 23 497 23 722 -0.95% | 28 994 | 33 646 | 40 818 |
|
EBITDA Million DKK | Released Forecast Spread | 5 616 5 721 -1.83% | 7 116 6 922 2.8% | 7 175 9 059 -20.79% | 8 716 | 12 478 | 17 161 |
|
EBIT Million DKK | Released Forecast Spread | 5 321 5 398 -1.42% | 7 003 6 441 8.72% | 6 727 8 479 -20.66% | 7 783 | 10 006 | 14 247 |
|
Earnings before Tax (EBT) Million DKK | Released Forecast Spread | 5 637 6 236 -9.6% | 9 164 7 411 23.66% | 7 605 9 329 -18.48% | 6 141 | 9 012 | 13 578 |
|
Net income Million DKK | Released Forecast Spread | 4 352 4 989 -12.77% | 7 844 5 530 41.86% | 6 083 7 428 -18.11% | 4 973 | 7 094 | 10 674 |
|
EPS DKK | Released Forecast Spread | 66,0 76,1 -13.23% | 121 85,3 42.26% | 97,1 118 -17.67% | 80,0 | 111 | 168 |
| Announcement Date | 14/02/24 | 12/02/25 | 17/02/26 | - |
Quarterly results
| Fiscal Period | June | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 S1 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million DKK | Released Forecast Spread | 6 441 6 396 0.7% | 4 731 5 019 -5.73% | 5 934 5 812 2.11% | 6 613 6 373 3.77% | 6 683 6 693 -0.15% | 5 691 5 673 0.33% | 7 493 7 232 3.6% | 13 305 13 446 -1.05% | 7 895 | 7 987 | 6 668 | 8 426 | 8 837 | 9 327 |
|
EBITDA Million DKK | Released Forecast Spread | 2 275 1 969 15.56% | 1 350 986 36.95% | 2 412 2 207 9.32% | 3 087 2 871 7.51% | 499 2 370 -78.95% | 2 601 3 709 -29.87% | 3 957 4 150 -4.66% | 4 390 | 2 744 | |||||
|
EBIT Million DKK | Released Forecast Spread | 2 191 1 945 12.67% | 1 244 1 069 16.32% | 2 310 2 074 11.36% | 2 970 2 445 21.46% | 366 2 259 -83.79% | 1 143 833 37.27% | 2 433 2 250 8.14% | 3 600 3 620 -0.55% | 2 403 | 2 061 | 1 591 | 3 382 | 3 987 | 4 163 |
|
Earnings before Tax (EBT) Million DKK | Released Forecast Spread | 3 602 1 942 85.46% | 1 615 1 214 32.96% | 2 714 2 174 24.81% | 3 119 2 491 25.22% | 347 2 220 -84.35% | 470 449 4.7% | 1 914 1 852 3.35% | 2 394 2 481 -3.52% | 1 964 | 1 768 | 1 098 | 2 899 | 3 519 | 3 714 |
|
Net income Million DKK | Released Forecast Spread | 3 845 1 576 143.95% | 1 290 1 068 20.84% | 2 156 1 657 30.06% | 2 595 1 927 34.67% | 196 1 638 -88.04% | 337 374 -9.97% | 1 966 1 425 37.95% | 2 309 1 781 29.7% | 1 509 | 1 238 | 857 | 2 261 | 2 745 | 2 897 |
|
EPS DKK | Released Forecast Spread | 59,6 24,3 145.14% | 20,2 16,0 26.14% | 34,8 24,5 42.1% | 41,8 30,3 37.77% | 2,97 28,5 -89.59% | 5,27 5,68 -7.11% | 31,9 22,8 39.7% | 37,2 28,8 29.05% | 25,0 | 21,1 | 12,7 | 28,0 | 31,7 | 37,1 |
| Announcement Date | 12/02/25 | 08/05/25 | 07/08/25 | 06/11/25 | 17/02/26 | 07/05/26 | 06/08/26 | 06/08/26 | - | - | - | - | - | - |
| Today |  | Annual General Meeting | 14:00 |
| 25/09/2026 | | Earnings presentation | 14:00 |
| 28/09/2026 | | Earnings release - Q2 2026 | |
| 28/09/2026 | | Earnings presentation | 13:00 |
| 29/09/2026 | | Extraordinary General Meeting | 07:00 |
| 29/09/2026 | | Information meeting | 13:00 |
| 06/10/2026 | | Information meeting | 15:00 |
| 14/10/2026 | | Présentation aux Actionnaires / Analystes | |
| 14/10/2026 | | Information meeting | 13:00 |
| 14/10/2026 | | Extraordinary General Meeting | 03:00 |
Past sector events for Genmab A/S
| Today | | Earnings presentation | 11:15 |
| 23/09/2026 | | Earnings presentation | 08:30 |
| 23/09/2026 | | Earnings release - Q2 2026 | |
| 23/09/2026 | | Board of Directors Meeting | |
| 22/09/2026 | | Information meeting | 13:30 |
| 22/09/2026 | | Information meeting | 13:00 |
| 22/09/2026 | | Earnings presentation | 06:00 |
| 22/09/2026 | | Annual General Meeting | |
| 22/09/2026 | | Présentation aux Actionnaires / Analystes | 13:00 |
| 22/09/2026 | | Earnings release - Q2 2026 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- GMAB Stock
- GMAB Stock
- Calendar Genmab A/S
Select your edition
All financial news and data tailored to specific country editions
